MATEC Indiana Office Temporarily Closed

UPDATED 11/1/18: The office building where MATEC Indiana is housed suffered significant water damage in late August. Our office will continue to be TEMPORARILY CLOSED until further notice.

During this time, MATEC Indiana will be taking on limited new programming. Staff is working remotely with limited access to equipment and supplies until the office is reopened. Staff can be reached most easily via email, and will continue to have access to their office voicemail.

To contact MATEC Indiana staff:

Malinda Boehler, Director
Email: mboehler@iupui.edu
Phone: (317) 880-3520

Karen Curd, Program Manager
Email: kcurd@iupui.edu
Phone: (317) 880-3519

Steve Everett, Special Projects Lead
Email: steveret@iu.edu
Phone: (317) 880-3527

Rachel Fogleman, Programming Coordinator
Email: rfoglema@iu.edu
Phone: (317) 880-3517

We apologize for any inconvenience this causes and will post updates as they become available.

Pap Rates for Indianapolis TGA Parts A and C Recipients, and Tips/Resources for Improving Pap Screening Rates

Source: Ibrahim Dandakoye Part A/MAI Grant and Quality Management Coordinator at the Marion County Public Health Department.
Published November 12, 2018

The Marion County Public Health Department’s Ryan White HIV Services Program (RWSP) manages Part A, Minority AIDS Initiative (MAI), and Part C funding to address the needs of people living with HIV (PLWH) in central Indiana, including those out of care or historically underserved or uninsured. The program helps out-of-care clients gain access to points of entry; provides a comprehensive HIV continuum of care; and complies with the National HIV/AIDS Strategy (NHAS). This article sought to encourage HIV providers to offer Papanicolaou (Pap) tests for all adult (18 years and older) HIV infected female patients seeking care.

About Cervical Cancer

Cervical cancer caused by Human Papillomavirus (HPV) is the most common gynecological cancer in women infected by HIV. Knowledge regarding cervical cancer cause and pathogenesis is rapidly expanding[1]. Persistent infection with one of about 15 genotypes of carcinogenic HPV causes almost all cases. There are four major steps in cervical cancer development: infection of metaplastic epithelium at the cervical transformation zone, viral persistence, progression of persistently infected epithelium to cervical pre-cancer, and invasion through the basement membrane of the epithelium. Infection is extremely common in young women in their first decade of sexual activity. Persistent infections and pre-cancer are established, typically within 5–10 years, from less than 10% of new infections. Invasive cancer arises over many years or decades, in a minority of women with pre-cancer, with a peak or plateau in risk at about 35–55 years of age. Each genotype of HPV acts as an independent infection, with differing carcinogenic risks linked to evolutionary species.

Continue reading Pap Rates for Indianapolis TGA Parts A and C Recipients, and Tips/Resources for Improving Pap Screening Rates

Public Health Epidemic Declared in Marion County due to Hepatitis C

On Thursday, May 17, 2018, the Marion County Public Health Department Director, Dr. Virginia Caine, declared a public health epidemic due to a 1,000 percent increase between 2013 and 2017 in Hepatitis C cases. In response to the epidemic, Dr. Caine is proposing a safe syringe exchange program for Marion County at the next City-County Council meeting on Monday, May 21st.

Continue reading Public Health Epidemic Declared in Marion County due to Hepatitis C

Drug Information Update: Dolutegravir and Neural Tube Birth Defects

The U.S. Food and Drug Administration (FDA) is alerting the public that serious cases of neural tube birth defects involving the brain, spine, and spinal cord have been reported in babies born to women treated with dolutegravir used to treat human immunodeficiency virus (HIV). Preliminary results from an ongoing observational study in Botswana found that women who received dolutegravir at the time of becoming pregnant or early in the first trimester appear to be at higher risk for these defects.

Continue reading Drug Information Update: Dolutegravir and Neural Tube Birth Defects

HIV Medication Updates from CROI 2018

Source: AETC National Coordinating Resource Center
Published April 12, 2018

Six new HIV Meds Updates have been added online to the AETC National Coordinating Resource Center’s (AETC NCRC) ShareSpot. Summaries include key findings and treatment updates from CROI 2018:

HIV Meds Updates are written by Susa Coffey, MD, medical editor of the AETC NCRC, and are posted as new treatment information becomes available.

Click here for other treatment updates, as well as more HIV/AIDS news.

Test and Treat: A New Model for Better Patient Outcomes

Source: AAHIVM’s HIV Specialist Magazine
Published April 2018

Congratulations to Brooke Stevens, PharmD, BCPS, AAHIVP, from IU Health LifeCare, along with Blake Max, PharmD, AAHIVP, from the University of Illinois in Chicago, on their recent article titled “Test and Treat: A New Model for Better Patient Outcomes” that was published in the April 2018 edition of AAHIVM’s HIV Specialist Magazine:

Continue reading Test and Treat: A New Model for Better Patient Outcomes

Local HIV Studies Actively Enrolling Research Participants

Source: Samir Gupta, MD, Indiana University School of Medicine
Published April 19, 2018

The Indiana Center for AIDS Research (CFAR) is working to increase collaborative research throughout the state of Indiana in all aspects of HIV/AIDS prevention and care. CFAR is currently conducting research in a variety of areas, including finding an HIV cure, improving quality of life for patients living with HIV, preventing new HIV infections, providing HIV care in resource-limited settings, and testing new HIV treatments.

To conduct successful research, CFAR needs community engagement from both people living with and without HIV. Currently, CFAR is seeking individuals to participate in their open studies. Community members interested in participating in open studies can click the link below or visit the IU School of Medicine’s Infectious Disease Clinical Research Program website by clicking here.

Click Here to Access the Current List of Studies 

 

For more information about CFAR and upcoming studies, visit the CFAR website by clicking here, or contact Samir Gupta, MD, at sgupta1@iu.edu or (317) 274-7926.

2018-2019 Clinician Scholars Program Applications Now Open

APPLICATIONS ACCEPTED THROUGH
JULY 15, 2018

Click Here to Access Application Materials
.

The MATEC Clinician Scholars Program is designed for front-line clinicians who are interested in expanding their capacity to provide HIV/AIDS care, and increase the number of clinicians that provide care to underserved or disproportionately affected populations.

Continue reading 2018-2019 Clinician Scholars Program Applications Now Open

Disparities in HIV Viral Suppression in Central Indiana

Source: Tammie L. Nelson, MPH, CPH, Epidemiology Manager at the Marion County Public Health Department
Published March 9, 2018

The Marion County Public Health Department’s Ryan White HIV Services Program (RWSP) manages Part A, Minority AIDS Initiative (MAI), and Part C funding to address the needs of people living with HIV (PLWH) in central Indiana, including those out of care or historically underserved or uninsured. The program helps out-of-care clients gain access to points of entry; provides a comprehensive HIV continuum of care; and complies with the National HIV/AIDS Strategy (NHAS).[1]

Viral load suppression is the ultimate measure of health for individuals living with HIV. Comparing HIV care outcomes over time or between groups of PLWH requires evaluation of community viral load (CVL) – an average of all viral load results taken from among PLWH in defined populations. Evaluating CVL is important to identify differences in HIV health outcomes among various populations. CVL analysis assists in identifying disparities in HIV care outcomes. The RWSP has undertaken a clinical quality management project to monitor differences in viral load among PLWH in Central Indiana. This project includes viral load analyses of PLWH in the Ryan White Part A transitional grant area (TGA). TGA counties include: Boone, Brown, Hamilton, Hancock, Hendricks, Johnson, Marion, Morgan, Putnam, and Shelby.

In 2017, 6,050 PLWH resided in the TGA, and health outcomes among these individuals have been improving. The percentage of the TGA’s HIV-positive residents who had suppressed viral loads increased from 50% to 64% during the period 2013-2017. These improved health outcomes were not equitable, however, and it is the goal of this article to identify disparities among PLWH in Central Indiana, arming both medical and supportive care providers with this knowledge so that resources can be focused to serve those who need help the most.

Continue reading Disparities in HIV Viral Suppression in Central Indiana